Addus HomeCare Announces Resignation of Simon Bachleda From Board of Directors

Tuesday, October 24, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

FRISCO, Texas, Oct. 23, 2017 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ:ADUS), a provider of comprehensive

home care services, announced today that Simon A. Bachleda, a member of its Board of Directors since September 2006, has tendered his resignation from the Board. Mr. Bachleda is leaving the
Board to be able to focus more on his responsibilities as Co?Founder and Managing Partner of Revelstoke Capital Partners. The Board has determined that it will not fill the vacancy left by Mr. Bachleda's departure at this time, and therefore, the size of the Board will be six directors.

Dirk Allison, President and Chief Executive Officer of Addus, commented, "Addus has been very fortunate to have Simon as a director for the last 11 years. We have greatly appreciated his expertise, guidance and hard work throughout his time as a director and a member of both our Audit and Compensation Committees. We thank Simon for his dedication to Addus and wish him well in his future endeavors."

About Addus Addus is a provider of comprehensive personal care services that are provided in the home and assist with activities of daily living. Addus' consumers are primarily persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus' payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. At June 30, 2017, Addus provided personal care services to approximately 34,000 consumers through 110 locations across 24 states. For more information, please visit www.addus.com.

View original content:http://www.prnewswire.com/news-releases/addus-homecare-announces-resignation-of-simon-bachleda-from-board-of-directors-300540724.html

SOURCE Addus HomeCare Corporation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store